Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Gustavo A. Barisone"'
Autor:
Gustavo A Barisone, Robert T O'Donnell, Yunpeng Ma, Mastewal W Abuhay, Kathleen Lundeberg, Sonia Gowda, Joseph M Tuscano
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190860 (2018)
Non-Hodgkin lymphoma (NHL) affects over 400,000 people in the United States; its incidence increases with age. Treatment options are numerous and expanding, yet efficacy is often limited by toxicity, particularly in the elderly. Nearly 70% patients e
Externí odkaz:
https://doaj.org/article/44b0fd5b681240d99a279d840eec10f3
Autor:
Clifford G. Tepper, Ashish Kumar, Gustavo A. Barisone, Joseph Tuscano, Ryan R. Davis, Joshua F. Meckler, Yuanzhi Lyu, Yoshihiro Izumiya, Ken-ichi Nakajima, Chanikarn Chantarasrivong, Kang-Hsin Wang, Hiroki Miura, Michiko Shimoda, Chie Izumiya
Publikováno v:
Communications biology, vol 4, iss 1
Communications Biology, Vol 4, Iss 1, Pp 1-17 (2021)
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-17 (2021)
Communications Biology
In herpesvirus replicating cells, host cell gene transcription is frequently down-regulated because important transcriptional apparatuses are appropriated by viral transcription factors. Here, we show a small peptide derived from the Kaposi’s sarco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e89597f01de0b7f650925e47833f44e5
https://escholarship.org/uc/item/3kf12319
https://escholarship.org/uc/item/3kf12319
Autor:
Clifford G. Tepper, Joseph Tuscano, Joshua F. Meckler, Kang-Hsin Wang, Gustavo A. Barisone, Michiko Shimoda, Ryan R. Davis, Hiroki Miura, Yuanzhi Lyu, Chie Izumiya, Yoshihiro Izumiya, Chanikarn Chantarasrivong, Ashish Kumar, Ken-ichi Nakajima
In herpesvirus replicating cells, host cell gene transcription is frequently down-regulated because important transcriptional apparatuses are appropriated by viral transcription factors. Here, we identified a small peptide derived from the Kaposi's s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ee5a87abc3f0fa7dff24df0ca134d7b
https://doi.org/10.21203/rs.3.rs-957900/v1
https://doi.org/10.21203/rs.3.rs-957900/v1
Autor:
Kathleen Lundeberg, Gustavo A. Barisone, Aaron S. Rosenberg, Mehrdad Abedi, Joseph Tuscano, Paul Kaesberg, Emily Schwab, Brian A. Jonas, Christina Poh
Publikováno v:
Journal of Hematology
Background: While many humanized monoclonal antibodies utilize complement-dependent cytotoxicity, the complement depleting effects of these antibodies and the impact of complement replacement on treatment response are not well-described. Methods: We
Autor:
Gustavo A Barisone, Tin Ngo, Martin Tran, Daniel Cortes, Mehdi H Shahi, Tuong-Vi Nguyen, Daniel Perez-Lanza, Wanna Matayasuwan, Elva Díaz
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e38508 (2012)
A subset of medulloblastomas, the most common brain tumor in children, is hypothesized to originate from granule neuron precursors (GNPs) in which the sonic hedgehog (SHH) pathway is over-activated. MXD3, a basic helix-look-helix zipper transcription
Externí odkaz:
https://doaj.org/article/33c07eab57864cfdbe4b21ae7ce12358
Autor:
Sakiko Yoshida, Nitin Nitin, Reuben Antony, Laurel A. Beckett, Cathy Chen, Connie P.M. Duong, Yueju Li, Noriko Satake, Elva D Diaz, Jan A. Nolta, Gustavo A. Barisone, Jong Hee Chung
Publikováno v:
Pediatric research
Duong, C; Yoshida, S; Chen, C; Barisone, G; Diaz, E; Li, Y; et al.(2017). Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA. Pediatric Research, 82(3), 527-535. doi: 10.1038/pr.2017.74. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/1s7524d7
Pediatric research, vol 82, iss 3
Duong, C; Yoshida, S; Chen, C; Barisone, G; Diaz, E; Li, Y; et al.(2017). Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA. Pediatric Research, 82(3), 527-535. doi: 10.1038/pr.2017.74. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/1s7524d7
Pediatric research, vol 82, iss 3
BackgroundNeuroblastoma is the second most common extracranial cancer in children. Current therapies for neuroblastoma, which use a combination of chemotherapy drugs, have limitations for high-risk subtypes and can cause significant long-term adverse
Autor:
Emily Tuscano, Gustavo A. Barisone, Mastewal Abuhay, Jason Kato, Robert T. O'Donnell, Ranjit S. Sidhu, Joseph Tuscano
Publikováno v:
Cancer immunology, immunotherapy : CII, vol 65, iss 10
Cancer Immunol Immunother
Cancer Immunol Immunother
In this study, the HB22.7 anti-CD22 mAb, was used for specific, targeted delivery of the potent anti-cancer agent, monomethyl auristatin E (MMAE) to non-Hodgkin lymphoma (NHL). MMAE was covalently coupled to HB22.7 through a valine-citrulline peptide
Publikováno v:
The Journal of Immunology. 204:239.27-239.27
Immunotherapy has revolutionized cancer therapy. Two of the most recently FDA-approved immunotherapies for B-cell malignancies target CD19, in the form of a Bispecific T-Cell Engager (BiTE) antibody construct or CAR-T cells. Blinatumomab, and FDA-app
Autor:
Mastewal Abuhay, Sonia Gowda, Kathleen Lundeberg, Gustavo A. Barisone, Joseph Tuscano, Robert T. O'Donnell, Yunpeng Ma
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 1, p e0190860 (2018)
PLoS ONE, Vol 13, Iss 1, p e0190860 (2018)
Non-Hodgkin lymphoma (NHL) affects over 400,000 people in the United States; its incidence increases with age. Treatment options are numerous and expanding, yet efficacy is often limited by toxicity, particularly in the elderly. Nearly 70% patients e
Autor:
Carly Lewis, Cathy Chen, Elva Dίaz, Jan A. Nolta, Noriko Satake, Kit S. Lam, Gustavo A. Barisone, Connie P.M. Duong
Publikováno v:
Blood cells, molecules & diseases, vol 54, iss 4
MXD3 is a transcription factor that plays an important role in proliferation of human DAOY medulloblastoma cells. Here, we demonstrate that MXD3 is highly enriched in human precursor B acute lymphoblastic leukemia (preB ALL) samples compared to mobil